[1] POON K,TAN K M,KOAY E S,et al.Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia[J].Hum Genome Var,2020,7(1):7.
[2] NADIA T,ADRIANA Z,MARINA C,et al.Glucokinase gene mutations:structural and genotype-phenotype analyses in MODY children from South Italy[J].PLoS One,2008,3(4):e1870.
[3] National Center for Biotechnology Information.GCK[DB/OL].[2020-03-16]:http://www.ncbi.nlm.nih.gov/
[4] AYÇA A,EMIN K,HVSEYIN O,et al.Analysis of the GCK gene in 79 MODY type 2 patients:a multicenter Turkish study,mutation profile and description of twenty novel mutations[J].Gene,2018,641:186-189.
[5] 王志新,于淼,郑佳,等.四例中国青少年的成人起病型糖尿病2型家系的临床与分子遗传学研究[J].中国糖尿病杂志,2014,6(1):21-26.
[6] OLIVEIRA S C,NEVES J S,PÉREZ A,et al.Maturity onset diabetes of the young:from a molecular basis perspective toward the clinical phenotype and proper management[J].Endocrinol Diabetes Nutr,2020,67(2):137-147.
[7] CHAKERA A J,STEELE A M,GLOYN A L,et al.Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation[J].Diabetes Care,2015,38(7):1383-1392.
[8] SHIELDS B M,PETERS J L,COOPER C,et al.Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature.[J].BMJ Open,2015,5(11):e009088.
[9] 邱友燕,何凌,陈子龙,等.1型糖尿病患者血清B细胞活化因子水平改变及其临床意义[J].现代医学,2018,46(8):863-866.
[10] PETTITT D J,TALTON J,DABELEA D,et al.Prevalence of diabetes in U.S.youth in 2009:the SEARCH for diabetes in youth study[J].Diabetes Care,2014,37(2):402-408.
[11] DANIōLE P M,FRCP C,ANKE S M,et al.A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry(SWEET)[J].Pediatr Diabetes,2016,17(s23):24-31.
[12] DELVECCHIO M,MOZZILLO E,SALZANO G,et al.Monogenic diabetes accounts for 6.3% of cases referred to 15 italian pediatric diabetes centers during 2007 to 2012[J].J Clin Endocrinol Metab,2017,102(6):1826-1834.
[13] PIHOKER C,GILLIAM L K,ELLARD S,et al.Prevalence,characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A,HNF4A,and glucokinase:results from the SEARCH for diabetes in youth[J].J Clin Endocrinol Metab,2013,98(10):4055-4062.
[14] HALILOG∨LU B,ABALI S,BUG∨RUL F,et al.The distribution of different types of diabetes in childhood:a single center experience[J].J Clin Res Pediatr Endocrinol,2018,10(2):125-130.
[15] ANNA M S,KIRSTY J W,SIAN E,et al.Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation:observational case control studies[J].PLoS One,2013,8(6):e65326.
[16] WAKIL S M,MUIYA N P,TAHIR A I,et al.A new susceptibility locus for myocardial infarction,hypertension,type 2 diabetes mellitus,and dyslipidemia on chromosome 12q24[J].Dis Markers,2014:291419.
[17] MOZZILLO E,SALZANO G,BARBETTI F,et al.Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents:impact of access to genetic testing[J].Diabetes Res Clin Pract,2015,107(3):e15-18.
[18] BURCUL I,ARAMBASIC N,POLIC B,et al.Characteristics of children with diabetic ketoacidosis treated in pediatric intensive care unit:two-center cross-sectional study in croatia[J].Medicine,2019,55(7):362.
[19] SCHOBER E,RAMI B,GRABERT M,et al.Phenotypical aspects of maturity-onset diabetes of the young(MODY diabetes) in comparison with type 2 diabetes mellitus(T2DM) in children and adolescents:experience from a large multicentre database[J].Diabet Med,2009,26(5):466-473.
[20] BEATA M,MACIEJ B,KAROLINA A,et al.Monogenic diabetes prevalence among Polish children-summary of 11 years-long nationwide genetic screening program[J].Pediatr Diabetes,2018,19(1):53-58.
[21] 中国2型糖尿病合并肥胖综合管理专家共识[J].糖尿病天地(临床),2016,10(10):449-451.
[22] ANNELIE C,MAGGIE S,SIAN E,et al.Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY:lessons from a 5-year pediatric Swedish national cohort study[J].Diabetes Care,2020,43(1):82-89.
[23] KLEINBERGER J W,POLLIN T I.Undiagnosed MODY:time for action.[J].Curr Diab Rep,2015,15(12):110.
[24] JOHANSEN A,EK J,MORTENSEN H B,et al.Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A,GCK,and TCF1[J].J Clin Endocrinol Metab,2005,90(8):4607-4614.
[25] STRIDE A,SHIELDS B,GILL C O,et al.Cross sectional and longitudinal studies suggest pharmacological treatment used in patients with glueokinase mutations desnotalter glycaemia[J].Diabetologia,2014,57(1):54-56. |
